Argatroban

Argatroban is a direct thrombin inhibitor

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) As an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI) 1.1 Heparin-Induced Thrombocytopenia Argatroban Injection is indicated
for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT). Percutaneous Coronary Intervention Argatroban Injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).
Do not take if: Patients with major bleeding,
Patients with a history of hypersensitivity to argatroban. Airway, skin, and generalized hypersensitivity reactions have been reported.

What it is used for

Argatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) As an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI) 1.1 Heparin-Induced Thrombocytopenia Argatroban Injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT).

Percutaneous Coronary Intervention Argatroban Injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).

Side effects, and when to stop

The following adverse reaction is also discussed in other sections of the labeling:

Risk of Hemorrhage.

Who should not take it

Argatroban is contraindicated in:

Patients with major bleeding,
Patients with a history of hypersensitivity to argatroban. Airway, skin, and generalized hypersensitivity reactions have been reported.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Argatroban; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/argatroban
APA 7th: sofidex. (2026, August 2). Argatroban. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/argatroban
AMA 11th: Argatroban. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/argatroban

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.